Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Sell

Security Buy Sell Buy (1M) Sell (1M) Price Target price ▲ Potential
Neogen Corp. 0 2 0 1 €14.10 - -
Cardiff Oncology Inc. 2 3 1 0 €2.34 - -
Salarius Pharmaceuticals Inc. 0 1 0 0 €0.39 - -
Vaxart Inc. 0 1 0 0 €0.74 - -
Coherus Bioscien. 1 2 1 0 €0.95 - -
Atara Biotherapeutics Inc. 1 2 0 0 €0.37 - -
Fibrogen Inc. 0 1 0 0 €0.35 - -
Minerva Neurosciences Inc. 0 13 0 3 €2.50 - -
Organovo Holdings Inc. 0 10 0 1 €0.43 - -
NanoVibronix Inc. 0 1 0 0 €0.48 - -
Synthetic Biologics Inc. 0 1 0 0 €0.12 - -
Enzo Biochem. Inc. 0 1 0 0 €1.00 - -
Natural Alternat. 21 1 3 0 €3.94 - -
InVivo Therapeutics Holdings 0 12 0 0 €0.31 - -
Evoke Pharma Inc. 0 24 0 1 €0.37 - -
Bellicum Pharmaceuticals Inc. 0 10 0 0 €0.064 - -
Palatin Technologies Inc. 0 1 0 0 €0.80 - -
Gritstone Oncology Inc 7 1 2 0 €0.17 €3.64 2001.499%
Cara Therapeutics Inc. 10 8 0 1 €0.25 €4.61 1763.813%
Aspira Womens Health Inc. 1 1 0 0 €0.73 €4.99 588.607%
Bluebird Bio Inc. 7 7 0 1 €0.51 €5.47 963.403%
Trevena Inc. 2 26 0 3 €0.15 €6.48 4136.601%
Fate Therapeutics Inc. 3 3 0 0 €2.90 €7.31 151.996%
Orasure Tech 4 1 1 0 €3.72 €8.36 124.685%
Glycomimetics Inc. 3 10 0 3 €0.14 €9.13 6278.911%